2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Ovarian Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thymus Neoplasms
1
Shoulder Disease
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma
1
Margins of Excision
1
Lung Neoplasms
1
Kidney Neoplasms
1
Hernia, Hiatal
1
Gastroesophageal Reflux
1
Esophageal Neoplasms
1
Esophageal Diseases
1
Esophageal Achalasia
1
Craniopharyngioma
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Breast Cancer Female
1
Adenocarcinoma
1
Interventions
Tamoxifen
4
Exercise
3
pyrotinib
2
abemaciclib
2
Paclitaxel
2
Metformin
2
Letrozole
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
Aromatase Inhibitors
2
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
palbociclib
1
iniparib
1
exemestane
1
durvalumab
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Tumor Burden
1
Tretinoin
1
Trastuzumab
1
Tocopherols
1
Thioctic Acid
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Cancer Female
×
Tumor Burden
×
Clear all
NCT04504747
2025-06-15
NEO-R
Institut Paoli-Calmettes
Recruiting
150 enrolled